A genetically engineered influenza A virus with ras-dependent oncolytic properties

Area of Science:

• Virology
• Oncology
• Immunology

Background:

• The influenza virus NS1 protein is a virulence factor that inhibits the host's PKR-mediated antiviral response.
• The delNS1 influenza virus, lacking the NS1 gene, cannot replicate in normal cells but can in PKR-deficient cells.
• Oncogenic ras is known to induce an inhibitor of PKR, suggesting a potential for selective viral replication.

Purpose of the Study:

• To investigate if the delNS1 virus selectively replicates in cells expressing oncogenic ras.
• To explore the oncolytic potential of the delNS1 virus against ras-driven tumors.

Main Methods:

• Transfection of cells with oncogenic N-ras to assess delNS1 virus replication.
• Monitoring of PKR activation during viral infection in oncogenic ras-expressing cells.
• In vivo studies using delNS1 virus treatment in mice with established N-ras-expressing melanomas.

Main Results:

• Cells expressing oncogenic N-ras became permissive for delNS1 virus replication.
• Viral replication in these cells was associated with reduced PKR activation.
• The delNS1 virus demonstrated tumor-ablative potential in a mouse melanoma model.
• The delNS1 virus did not replicate in nonmalignant cell lines.

Conclusions:

• The delNS1 virus exhibits selective oncolytic properties against cells with activated ras signaling.
• Its apathogenic nature and selective replication make it a promising candidate for treating ras-driven tumors.